Posted on 1/10/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, announces today that it has successfully implanted the first lenses in the RayOne Galaxy IOL U.S. Food and Drug Administration (FDA) approved Investigational Device Exemption (IDE) Study. The study is prospective, multicenter, randomised, masked and active controlled. If successful, the results of
Posted on 27/08/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces the upcoming launch of the world’s first spiral IOL designed with artificial intelligence: RayOne Galaxy and Galaxy Toric. Launching at this year’s ESCRS Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the
Posted on 27/06/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and
Posted on 6/06/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces three new appointments to its management board, forming part of ongoing growth and development in the organisation. James Crutchlow has been appointed as Chief Commercial Officer, Rob Nadler as Chief Growth Officer and Chris Willis as Chief Marketing Officer, effective immediately. “This important
Posted on 5/04/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling
Posted on 25/03/2024
Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, is proud to introduce their latest packaging, updated to reduce their carbon footprint, as a contribution to their environmental goals, and to improve ease of use for customers. The new packaging will include: Replacing traditional paper IFU documents with a QR code
Posted on 23/01/2024
Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor Graham Barrett, RayOne EMV is the only patented aspheric IOL that induces controlled positive spherical aberration to slightly extend the depth of focus. “I’ve been awaiting
Posted on 16/01/2024
17/01/2024 | Rayner, a global leader in products for cataract surgery, headquartered in Worthing, UK, announces today that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines. Throughout its 114-year history, Rayner has been at the forefront of innovation in ophthalmology and
Posted on 21/12/2023
Rayner, a global manufacturer of products for cataract surgery, is delighted to have scored within the top 17% of companies in the 2023 EcoVadis ratings. EcoVadis is the world’s largest provider of business sustainability ratings, assessing a global network of over 100,000 companies. The first of Rayner’s assessments in 2022 resulted in a respectable Bronze
Posted on 14/12/2023
Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, has introduced a number of beehives to their site to contribute towards their environmental and social responsibility goals for this year. Honeybees are known to be vital in pollinating food sources and wild plants, supporting biodiversity and maintaining the ecosystem, as well